Daratumumab, Lenalidomide, and Dexamethasone (DRD), an Active Regimen in the Treatment of Immunosuppression-Associated Plasmablastic Lymphoma (PBL) in the Setting of Gorham's Lymphangiomatosis: Review of the Literature

Characterized by an aggressive course with a poor overall survival due to treatment refractoriness, plasmablastic lymphoma (PBL) is a rare variant of diffuse large cell B cell lymphoma. Gorham's lymphangiomatosis or Gorham–Stout disease (GSD) is a rare skeletal condition of unknown etiology cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Matthew, Martin, Beth A., Abdulhaq, Haifaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252825/
https://www.ncbi.nlm.nih.gov/pubmed/35795542
http://dx.doi.org/10.1155/2022/8331766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252825/
https://www.ncbi.nlm.nih.gov/pubmed/35795542
http://dx.doi.org/10.1155/2022/8331766

Ejemplares similares